NO914649L - INCLUSION COMPLEXES OF N-ETHOXYCARBONYL-3-MORPHOLINO-SYDNONIMINE OR ITS SALTS FORMED WITH CYLODEXTRIN DERIVATIVES, PREPARING THESE AND PHARMACEUTICAL PREPARATIONS CONTAINING - Google Patents

INCLUSION COMPLEXES OF N-ETHOXYCARBONYL-3-MORPHOLINO-SYDNONIMINE OR ITS SALTS FORMED WITH CYLODEXTRIN DERIVATIVES, PREPARING THESE AND PHARMACEUTICAL PREPARATIONS CONTAINING

Info

Publication number
NO914649L
NO914649L NO91914649A NO914649A NO914649L NO 914649 L NO914649 L NO 914649L NO 91914649 A NO91914649 A NO 91914649A NO 914649 A NO914649 A NO 914649A NO 914649 L NO914649 L NO 914649L
Authority
NO
Norway
Prior art keywords
cyclodextrin
sydnonimine
ethoxycarbonyl
morpholino
cylodextrin
Prior art date
Application number
NO91914649A
Other languages
Norwegian (no)
Other versions
NO914649D0 (en
NO179611B (en
NO179611C (en
Inventor
Maria Vikmon
Jozsef Szejtli
Jozsef Gaal
Istvan Hermecz
Agnes Hovarth
Katalin Marmarosi
Gabor Hovarth
Iren Munkacsi
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO914649D0 publication Critical patent/NO914649D0/en
Publication of NO914649L publication Critical patent/NO914649L/en
Publication of NO179611B publication Critical patent/NO179611B/en
Publication of NO179611C publication Critical patent/NO179611C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Clathrates (I) of N-ethoxycarbonyl-3- morpholino-sydnonimine (II) or its salts with cyclodextrin derivs. (III) are new. N.B., cpds. (III) include unsubstd. beta- and gamma-cyclodextrins. (II) is an anti-angina and anti-ischaemic agent (molsidomin) useful for prevention and treatment of angina pectoris. It also has antiarrhythmic, fibrinolytic, platelet aggregation inhibitory and hypotensive activity. Pref. (III) are selected from beta-cyclodextrin (BCD), gamma-cyclodextrin, heptakis-2,6,O-dimethyl -beta-cyclodextrin and hydroxypropyl- beta-cyclodextrin.
NO914649A 1990-03-28 1991-11-27 Process for Preparation of an Inclusion Complex of N-Ethoxycarbonyl-3-Morpholinosydnonimine or Its Salt Formed with a Cyclodextrin Derivative NO179611C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU901868A HU210921B (en) 1990-03-28 1990-03-28 Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
PCT/HU1991/000012 WO1991014680A1 (en) 1990-03-28 1991-03-28 Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same

Publications (4)

Publication Number Publication Date
NO914649D0 NO914649D0 (en) 1991-11-27
NO914649L true NO914649L (en) 1991-11-27
NO179611B NO179611B (en) 1996-08-05
NO179611C NO179611C (en) 1996-11-13

Family

ID=10956592

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914649A NO179611C (en) 1990-03-28 1991-11-27 Process for Preparation of an Inclusion Complex of N-Ethoxycarbonyl-3-Morpholinosydnonimine or Its Salt Formed with a Cyclodextrin Derivative

Country Status (34)

Country Link
US (1) US5403840A (en)
EP (1) EP0477315B1 (en)
JP (1) JP2582497B2 (en)
KR (1) KR950004705B1 (en)
CN (1) CN1051080C (en)
AT (1) ATE138656T1 (en)
AU (1) AU638824B2 (en)
BG (1) BG61689B1 (en)
BR (1) BR9105136A (en)
CA (1) CA2054188C (en)
CZ (1) CZ287353B6 (en)
DE (1) DE69119853T2 (en)
DK (1) DK0477315T3 (en)
ES (1) ES2090320T3 (en)
FI (1) FI102460B (en)
GE (1) GEP19991832B (en)
GR (1) GR3020684T3 (en)
HR (1) HRP920561B1 (en)
HU (1) HU210921B (en)
IL (1) IL97714A (en)
LT (1) LT3394B (en)
LV (1) LV10245B (en)
MC (1) MC2185A1 (en)
MD (1) MD679G2 (en)
NO (1) NO179611C (en)
OA (1) OA10029A (en)
PL (1) PL165868B1 (en)
RO (1) RO109649B1 (en)
RU (1) RU2111216C1 (en)
SI (1) SI9110908A (en)
SK (1) SK279891B6 (en)
TJ (1) TJ231R3 (en)
UA (1) UA27226C2 (en)
WO (1) WO1991014680A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
FR2805462B1 (en) * 2000-02-24 2003-08-15 Therabel Res NEW ORAL GALENIC FORM WITH EXTENDED RELEASE OF MOLSIDOMINE
ITTO20120056A1 (en) * 2012-01-24 2013-07-25 Borla Ind CONNECTOR FOR MEDICAL LINES OF INFUSION, TRANSFUSION AND THE LIKE
ITTO20130433A1 (en) * 2013-05-29 2014-11-30 Borla Ind CONNECTOR FOR MEDICAL LINES
BE1028879B1 (en) 2020-12-11 2022-07-12 Europharmaceuticals Molsidomine Sustained-Release Tablet

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695897C3 (en) * 1966-07-04 1979-02-15 Takeda Chemical Industries Ltd N-acyl-sydnonimines, their salts, processes for their preparation and medicaments containing these compounds
DE3221425A1 (en) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim HYDROLYSIS-SENSITIVE ACTIVE SUBSTANCE CONTAINING STORAGE TABLET
DK243084A (en) 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd PERCUTANEOUS PHARMACEUTICAL PREPARATIONS FOR EXTERNAL USE
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (en) * 1985-06-21 1987-01-15 Cassella Ag PHOTOSTABILIZATION OF SYDNONIMINES
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (en) * 1986-12-26 1996-02-28 日清製粉株式会社 Sustained-release pharmaceutical preparation
IT1204725B (en) * 1987-06-17 1989-03-10 Edmond Pharma Srl DIPYRIDAMOL INCLUSION COMPLEXES WITH CYCLODESTRINE
ES2037385T3 (en) * 1988-01-14 1993-06-16 Akzo N.V. A MANUFACTURING PROCEDURE OF A PHARMACEUTICAL PREPARATION FOR LOCAL ADMINISTRATION.
US5120732A (en) * 1988-06-14 1992-06-09 Cassella Aktiengesellschaft Substituted 3-aminosyndone imines, a process for their preparation and their use
IT1227626B (en) * 1988-11-28 1991-04-23 Vectorpharma Int SUPPORTED DRUGS WITH INCREASED DISSOLUTION SPEED AND PROCEDURE FOR THEIR PREPARATION
SE8904296D0 (en) * 1989-12-21 1989-12-21 Pharmacia Ab TRANSDERMAL SYSTEM
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
LV10245A (en) 1994-10-20
PL293022A1 (en) 1992-12-28
DK0477315T3 (en) 1996-09-30
LT3394B (en) 1995-09-25
CN1051080C (en) 2000-04-05
KR920701182A (en) 1992-08-11
NO914649D0 (en) 1991-11-27
GEP19991832B (en) 1999-11-05
FI102460B1 (en) 1998-12-15
LTIP386A (en) 1994-12-27
EP0477315A1 (en) 1992-04-01
OA10029A (en) 1996-10-14
DE69119853D1 (en) 1996-07-04
BR9105136A (en) 1992-08-04
HU901868D0 (en) 1990-08-28
TJ231R3 (en) 1999-11-24
NO179611B (en) 1996-08-05
MD679G2 (en) 1997-11-30
EP0477315B1 (en) 1996-05-29
FI915569A0 (en) 1991-11-26
AU638824B2 (en) 1993-07-08
HU210921B (en) 1995-09-28
CA2054188C (en) 1996-07-23
CS85191A3 (en) 1991-11-12
HRP920561B1 (en) 1999-12-31
ATE138656T1 (en) 1996-06-15
HRP920561A2 (en) 1994-04-30
DE69119853T2 (en) 1996-10-10
FI102460B (en) 1998-12-15
JPH04506362A (en) 1992-11-05
SK279891B6 (en) 1999-05-07
BG61689B1 (en) 1998-03-31
US5403840A (en) 1995-04-04
RO109649B1 (en) 1995-04-28
LV10245B (en) 1995-08-20
CZ287353B6 (en) 2000-11-15
MD679F1 (en) 1997-02-28
UA27226C2 (en) 2000-08-15
NO179611C (en) 1996-11-13
IL97714A0 (en) 1992-06-21
CA2054188A1 (en) 1991-09-29
AU7574591A (en) 1991-10-21
MC2185A1 (en) 1992-09-16
KR950004705B1 (en) 1995-05-04
SI9110908A (en) 1998-06-30
RU2111216C1 (en) 1998-05-20
WO1991014680A1 (en) 1991-10-03
CN1056688A (en) 1991-12-04
PL165868B1 (en) 1995-02-28
HUT58109A (en) 1992-01-28
GR3020684T3 (en) 1996-10-31
ES2090320T3 (en) 1996-10-16
JP2582497B2 (en) 1997-02-19
IL97714A (en) 1995-03-30
BG95531A (en) 1993-12-24

Similar Documents

Publication Publication Date Title
IE893201L (en) Method and compositions for solubilization and stabilization¹of polypeptides, especially proteins
NO914649D0 (en) INCLUSION COMPLEXES OF N-ETHOXYCARBONYL-3-MORPHOLINO-SYDNONIMINE OR ITS SALTS FORMED WITH CYLODEXTRIN DERIVATIVES, PREPARING THESE AND PHARMACEUTICAL PREPARATIONS CONTAINING
HUT62198A (en) Erythropoietin compositions comprising cyclodextrin
TJ275B (en) Derivatives of cyclodextrins exhibiting enhenced aqueous solubility and the use thereof
EP0214647A3 (en) Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
EP0300526A3 (en) Antiviral pharmaceutical compositions containing cyclodextrins
AU3854095A (en) Novel complexes and their compositions
DE69214355D1 (en) Agents containing hepatocyte growth factor
NO307570B1 (en) Inclusion complexes obtained from nimesulide alkali and nimesulide alkaline earth salts and cyclodextrins or cyclodextrin derivatives, as well as pharmaceutical preparations containing said inclusion complex and process for preparing the same
EP0422497A3 (en) Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them
FI102462B1 (en) A process for the preparation of a cyclodextrin complex of nimesulide
ATE386527T1 (en) INCLUSION COMPLEX OF TUBERCULOSTATIC RIFAMPICIN WITH BETA-CYCLODEXTRIN OR 2-HYDROXYPROPYL BETA-CYCLODEXTRIN AND A PROCESS FOR PRODUCING THE SAME
DE69618496D1 (en) Process for the derivatization of polyglucosamines
De Hassonville et al. Inclusion complexes of cyproterone acetate with cyclodextrins in aqueous solution
Lee et al. Phamaceutical Studies on the Drug (III)-Enhancement of Dissolution and Stability of Sulfamethoxazole by ${\beta}-Cyclodextrin $ Complexation
ES2094080A1 (en) Procedure for the preparation of inclusion complexes of tenoxicam with ciclodextrines. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
MK1K Patent expired